A Medical Device Daily

Immucor (Norcross, Georgia), a provider of automated instrument-reagent systems to the blood transfusion industry, reported that it has entered into a long-term agreement with Canadian Blood Services for the purchase of five Galileo instruments and the related reagents.

Dr. Nino De Chirico, president of Immucor, said, “They will initially implement antibody screening. At a later date, Canadian Blood Services could add additional tests to the menu on the instrument as a second-phase implementation.”

Immucor makes a line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion.

Canadian Blood Services is a national, not-for-profit organization that manages the blood supply in all provinces and territories outside of Quebec and oversees the country’s Unrelated Bone Marrow Donor Registry.

The organization operates 42 permanent collection sites and more than 15,000 donor clinics annually. The provincial and territorial ministers of health provide operational funding to Canadian Blood Services.

The federal government, through Health Canada, is responsible for regulating the blood system.

Premier Purchasing Partners (Carlsbad, California), the healthcare group purchasing unit of Premier (San Diego), has awarded Smiths Medical (Weston, Massachusetts) participation in a multi-source agreement which includes its line of Logical pressure monitoring systems and TranStar pressure monitoring transducers.

The three-year contract, effective July 1, represents a $22 million opportunity over the contract period, Smiths said.

Dominick Arena, president of Smiths Medical Critical Care, said, “Participation in this contract . . . represents an opportunity to build and strengthen our existing strong relationships.

Smiths Medical makes medical devices used for a variety of therapeutic, diagnostic and surgical procedures.

Focus Diagnostics (Herndon, Virginia) reported signing a three-year referral testing service agreement with Child Health Corp. of America (CHCA; Overland Park, Kansas), a business alliance of 41 children’s hospitals in North America. The agreement will commence on July 1.

Focus Diagnostics, a provider of infectious disease diagnostics for nearly three decades, says it “seeks to understand the unique medical needs of children, such as the need to accommodate smaller sample sizes.”

No Comments